Phase 1 Breast Cancer Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women who weigh at least 50 kg and have a Body Mass Index (BMI) between 19 and 39.
- Women who have gone through menopause.
- Women who have been diagnosed with a specific type of early-stage breast cancer (HR+/HER2- or HR+/HER2+), have finished at least 5 years of hormone-blocking treatment, and at least 2 of those years involved a medicine called letrozole — or, for women considered by their doctor to be at low risk of the cancer returning, at least 4 years of hormone-blocking treatment with at least 2 of those years on letrozole.
- Women who are generally in good health.
- Women who have had a breast scan (such as a mammogram) within the past 12 months showing no signs of cancer, or who are willing to have one done before the trial starts.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have a serious medical condition that is not well managed or stable.
- People who have used certain hormonal treatments — including estrogen, progesterone, oral contraceptives, or related medications — in the 3 months before screening.
- People currently using certain medicines that affect how the body processes drugs (specifically those that affect enzymes called CYP3A4 and CYP2A6) (confirm with trial site).
- People who have been diagnosed with osteoporosis.
- People who have a pre-existing heart or blood vessel (cardiovascular) condition.
- People who have tested positive for hepatitis B, hepatitis C, or HIV.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +34913756230
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Area under the concentration-time curve within a dosing interval at Steady-State (SS AUCtau)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 10 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.